Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia

Journal:
JAMA: The Journal of the American Medical Association
Published:
DOI:
10.1001/jama.2025.20620
Affiliations:
11
Authors:
12
Institutions Authors Share
Merck & Co, United States of America (USA)
3.000000
0.25
MSD Argentina, Argentina
1.000000
0.08
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
1.000000
0.08
New Zealand Clinical Research (NZCR), New Zealand
1.000000
0.08
MSD R&D (China) Co., Ltd., China
1.000000
0.08
Montreal Heart Institute, UdeM, Canada
1.000000
0.08
Texas Heart Institute (THI), United States of America (USA)
1.000000
0.08
Amsterdam Cardiovascular Sciences, Netherlands
1.000000
0.08
Oslo University Hospital (OUS), Norway
1.000000
0.08
University of Milan (UNIMI), Italy
0.500000
0.04
IRCCS MultiMedica, Italy
0.500000
0.04